0001127602-20-015179.txt : 20200504
0001127602-20-015179.hdr.sgml : 20200504
20200504160812
ACCESSION NUMBER: 0001127602-20-015179
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200430
FILED AS OF DATE: 20200504
DATE AS OF CHANGE: 20200504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Doyle Anthony
CENTRAL INDEX KEY: 0001808688
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 20844923
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BLVD.
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-04-30
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001808688
Doyle Anthony
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Chief Financial Officer
Emp. Stock Option (Right to Buy)
3.91
2020-04-30
4
A
0
600000
0
A
2021-04-30
2020-04-30
Common Stock
600000
600000
D
Initial Employee Option Grant, 200,000 of which become exercisable on the first anniversary of the grant date or upon termination if, within the first year of his employment, Mr. Doyle is impacted by a reduction in force at the Company, and the remainder of which will vest in three equal installments on the second, third and fourth anniversaries of the grant date.
/s/ Alane P. Barnes, by power of attorney
2020-05-04